Literature DB >> 1589302

The Wellcome Trust Lecture. Infection and disease in lymphatic filariasis: an immunological perspective.

E A Ottesen1.   

Abstract

The basic tenet of the immunological perspective of filarial disease is that differential immune responsiveness among individuals exposed to infection results in the different clinical manifestations that develop. The mechanisms involved in this differential responsiveness appear to reflect different T-cell cytokine response patterns. Asymptomatic patients with the clinically silent presentation of 'asymptomatic microfilaraemia', who have been previously described as being 'immunosuppressed' with respect to their generating pro-inflammatory (Th1-type) immune responses to parasite antigen, are now recognized to be fully responsive to parasite antigen but to produce cytokines and mediators that have primarily anti-inflammatory (Th2-like) effects. Studies with immunodeficient mice have indicated the existence of two alternative pathways to the development of lymphatic pathology: one dependent on the induction of inflammatory reactions by the host immune response, the other entirely independent of the immune system and reflecting the direct actions of the parasite or its products on the lymphatics. As histopathology of affected human lymphatics is consistent with this hypothesis, it may be that the lymphatic pathology seen normally in the amicrofilaraemic, highly immunoresponsive infected patients derives from inflammation induced by immune responses to parasite antigen, whereas the lymphatic pathology sometimes seen coexisting with the 'immunosuppressed' state of asymptomatic microfilaraemia actually reflects lymphatic damage that is not immunologically mediated. Though little information exists about the 'natural history' of lymphatic filariasis, there is no evidence for an inevitable progression from one clinical form to another.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1589302     DOI: 10.1017/s0031182000075259

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  37 in total

1.  Human bancroftian filariasis - a role for antibodies to parasite carbohydrates.

Authors:  M C Mohanty; A K Satapathy; P K Sahoo; B Ravindran
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Cloning and characterization of high mobility group box protein 1 (HMGB1) of Wuchereria bancrofti and Brugia malayi.

Authors:  Sivasakthivel Thirugnanam; Gnanasekar Munirathinam; Anandharaman Veerapathran; Gajalakshmi Dakshinamoorthy; Maryada V Reddy; Kalyanasundaram Ramaswamy
Journal:  Parasitol Res       Date:  2012-03-09       Impact factor: 2.289

3.  Molecular characterization of an rsmD-like rRNA methyltransferase from the Wolbachia endosymbiont of Brugia malayi and antifilarial activity of specific inhibitors of the enzyme.

Authors:  Ajay Kumar Rana; Sharat Chandra; Mohammad Imran Siddiqi; Shailja Misra-Bhattacharya
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

4.  Interleukin-12 suppresses immunoglobulin E production but enhances immunoglobulin G4 production by human peripheral blood mononuclear cells.

Authors:  B A de Boer; Y C Kruize; P J Rotmans; M Yazdanbakhsh
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors:  W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.

Authors:  P T Soboslay; S M Geiger; N Weiss; M Banla; C G Lüder; C M Dreweck; E Batchassi; B A Boatin; A Stadler; H Schulz-Key
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

7.  Cytostatic and cytotoxic effects of activated macrophages and nitric oxide donors on Brugia malayi.

Authors:  G R Thomas; M McCrossan; M E Selkirk
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

8.  Fine specificity of the genetically controlled immune response to native and recombinant gp15/400 (polyprotein allergen) of Brugia malayi.

Authors:  J E Allen; R A Lawrence; R M Maizels
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

9.  Differential antibody isotype reactivity to specific antigens in human lymphatic filariasis: gp15/400 preferentially induces immunoglobulin E (IgE), IgG4, and IgG2.

Authors:  M Yazdanbakhsh; W A Paxton; A Brandenburg; R Van Ree; M Lens; F Partono; R M Maizels; M E Selkirk
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Induction of murine T-helper-cell responses to the filarial nematode Brugia malayi.

Authors:  E Pearlman; F E Hazlett; W H Boom; J W Kazura
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.